Decreased mRNA Expression of Several Basement Membrane Components in Basal Cell Carcinoma  by Chopra, Ameeta et al.
Decreased mRNA Expression of Several Basement Membrane
Components in Basal Cell Carcinoma
Ameeta Chopra, Basabi Maitra, and Neil J. Korman
Department of Dermatology, Skin Diseases Research Center, Case Western Reserve University, University Hospitals of Cleveland, Cleveland, Ohio, U.S.A.
The biologic factors that control the behavior of basal
cell carcinoma are poorly understood. This study was
undertaken to elucidate the mechanisms responsible for
the altered protein levels of several basement membrane
components found in basal cell carcinoma. RNA was
isolated from papulonodular basal cell carcinoma, normal
human epidermal keratinocytes, and normal human skin,
reverse transcribed to cDNA and amplified by the poly-
merase chain reaction utilizing primers specific for the
230 kDa bullous pemphigoid antigen (BPAG1), the
180 kDa bullous pemphigoid antigen (BPAG2), the a6
and b4 chains of the a6b4 integrin complex, and the b3
chain of laminin 5. Southern blots probed with internal
oligonucleotides confirmed that each polymerase chain
reaction was specific for the basement membrane com-
ponent amplified. The mRNA expressions of basement
membrane components were indistinguishable between
normal human epidermal keratinocytes and normal
human skin, and subsequent experiments used normal
Basal cell carcinoma (BCC) is the most common humancancer (Miller, 1991; Lang and Maize, 1991). Althoughthese tumors are readily treatable and usually have a goodprognosis, many can become aggressive with significantlocal tissue invasion and destruction. The major etiologic
factor related to the development of BCC is chronic exposure to solar
ultraviolet radiation (Miller, 1991; Lang and Maize, 1991). Depletion
of the ozone layer, which aids in filtering out the carcinogenic
ultraviolet radiation, seems very likely to contribute to an increased
incidence of BCC in the future. Although there is some understanding
of the elements related to the development of BCC, little is known
about the biologic features that control the behavior of this tumor.
The factors responsible for the relatively slow growth and local
invasion of BCC are not well understood, but one popular model
proposes a major role for proteolytic degradation of the basement
membrane (BM) (Liotta et al, 1984). Support for this general model
in BCC is derived from the observation that there are increased levels
of type I collagenase in papulonodular BCC, and the more aggressive
morpheaform BCC display increased levels of both type I and type IV
collagenase (Barsky et al, 1987). Although BM contain numerous
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human epidermal keratinocytes as controls. Quantitation
of polymerase chain reaction products indicated that all
basement membrane specific mRNA were significantly
decreased in basal cell carcinoma as compared with
normal human epidermal keratinocytes. The mean poly-
merase chain reaction product intensities were signific-
antly less in the basal cell carcinoma as compared with the
normal human epidermal keratinocytes at the following
levels: p < 0.001 for a6 and b4 integrins and the b3 chain
of laminin 5; p < 0.01 for BPAG1; and p < 0.05 for
BPAG2. Our results demonstrate that decreased protein
levels of basement membrane components in basal cell
carcinoma are due at least partially to a downregulation
of basement membrane mRNA species. We speculate that
these alterations may lead to a structurally incompetent
basement membrane that facilitates the basal cell carcin-
oma ability to invade tissues. Key words: α6β4 integrin/
bullous pemphigoid antigens/epidermal basement membrane
zone/non-melanoma skin cancer. J Invest Dermatol 110:52–
56, 1998
components, recent studies suggest that type IV collagen may form
the scaffolding upon which other BM components are assembled
(Stetler-Stevenson, 1990). These findings suggest that there may be a
correlation between degradation of type IV collagen by type IV
collagenase in morpheaform BCC and the relatively aggressive behavior
of these tumors, and convey the important point that intact BM may
be required to prevent extensive and aggressive tumor island invasion.
In addition to BM degradation by proteolytic enzymes, it is also
plausible to consider that BCC may be incapable of adequate synthesis
of BM components, thereby allowing for a leaky BM that facilitates
BCC tumor invasion. Support for the concept of inadequate synthesis
of BM components was originally provided by Stanley et al who
demonstrated a specific antigenic defect of the BM in BCC. They
found that most BCC had undetectable tumor BM bullous pemphigoid
antigen whereas the overlying epidermis showed normal expression of
bullous pemphigoid antigen (Stanley et al, 1982a). Type IV collagen
and laminin 1 were both equally expressed in the BM of normal
epidermis and around BCC tumor islands in the dermis. Since these
original studies, many investigators have demonstrated that the BM
of BCC contains extensive abnormalities in numerous constituents
including several components of the hemidesmosomes, anchoring
filaments, and anchoring fibrils. Undetectable or diminished levels of
the 230 kDa bullous pemphigoid antigen (BPAG1), the 180 kDa
bullous pemphigoid antigen (BPAG2), laminin 5 (Lam 5) (previously
known as epiligrin), the α6 and β4 subunits of the α6β4 integrin,
plectin, uncein, the linear IgA disease antigen, and type VII collagen
have all been observed (Sollberg et al, 1992; Korman and Hrabovsky,
1993; Savoia et al, 1993; Fairley et al, 1995; Lazarova et al, 1995;
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Bahadoran et al, 1997). As the hemidesmosome anchoring filament/
fibril complex is thought to play an important role in epidermal cell
adhesion to the BM, these observations suggest that these extensive
BM abnormalities could facilitate or contribute to BCC tumor invasion.
In the present study we have investigated the underlying mechanism
for our previous observation that the tumor BM protein expression of
several components of the hemidesmosome anchoring fibril complex
is significantly altered in BCC (Korman and Hrabovsky, 1993). We
analyzed the mRNA levels of BPAG1, BPAG2, the α6 and β4 subunits
of the α6β4 integrin, and the β3 chain of Lam 5 using reverse
transcriptase polymerase chain reaction (RT-PCR) in papulonodular
BCC tumor specimens and compared these levels with those found
in both normal human skin (NHS) and normal human epidermal
keratinocytes.
MATERIALS AND METHODS
Sample collection NHS samples were obtained from volunteers, using a
keratome set at 0.4 mm, snap-frozen in liquid nitrogen, and stored at –70°C.
Primary keratinocyte cultures were established from NHS obtained from
autopsies within 6 h of death. Keratinocytes were obtained from 70–80%
confluent cultures that were in the second passage.
Fresh papulonodular BCC were obtained as discarded tissue at the time of
Moh’s surgery. A small piece of tissue was removed from the center of the
tissue to obtain histologic confirmation of the diagnosis of BCC. The remaining
tissue was snap-frozen by pouring liquid nitrogen over it. The tissue was stored
at –70°C until ready for use.
RNA isolation and cDNA synthesis Total RNA was extracted from skin
samples homogenized using a well-accepted method (Chomzynski and Sacchi,
1987). Briefly, the samples were homogenized in 4 M guanidium thiocyanate
lysis buffer, phenol-chloroform extracted, layered on a 5.7 M CsCl gradient,
and ultracentrifuged at 35,000 rpm for 20 h. The resulting RNA pellet was
dissolved in diethylpyrocarbonate-treated double deionized water, purified by
ammonium acetate–ethanol precipitation, ethanol washed, and redissolved in
diethylpyrocarbonate-treated double deionized water. The quantity and quality
of isolated RNA was assessed by spectroscopy and electrophoresis on formalde-
hyde agarose gels containing ethidium bromide.
Total RNA was reverse transcribed using oligo dT and moloney murine
leukemia virus reverse transcriptase with the following assay conditions: 5 µg
RNA in TE buffer, pH 8.0 (10 mM Tris, 1 mM ethylenediamine tetraacetic
acid), 0.5 µg oligo (dT)15, 0.5 mM each of dATP, dCTP, dGTP, dTTP,
1 3 reverse transcriptase buffer (Gibco BRL kit, Gaithersburg, MD), 10 mM
dithiothreitol, 40 U RNase inhibitor, and 200 U moloney murine leukemia
virus reverse transcriptase. cDNA was then synthesized by heating at 42°C for
60 min and the reaction was stopped by heating at 90°C for 5 min.
Polymerase chain reaction (PCR) analysis The cDNA was amplified
using primers specific for BPAG1, BPAG2, the α6 and β4 integrin subunits,
Lam 5 (the β3 chain), and hypoxanthine guanine phosphoribosyl transferase
(HGPRT). The PCR reaction mixture of 50 µl, consisting of 10 mM Tris-
HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl2, 0.2 mM of each dNTP, 1.0 µM
of each oligonucleotide primer, and 1.25 U of Taq polymerase per PCR
reaction, was amplified using the GeneAmp PCR system 9600 (Perkin Elmer,
Branchburg, NJ). Each PCR run consisted of 35 cycles of denaturation at
94°C, annealing at 55–60°C (which differed depending upon the sequence
being amplified), and extension at 72°C. The BPAG1 sense primer was
ATGAGAACAATTGAGCAGCTGC, the anti-sense primer was GGCAAT-
CTGGGCTTCCAAGATATGT, and annealing was at 56°C for 90 s (Sawamura
et al, 1991). The BPAG2 sense primer was TCCAGCGGCTCTCCTGGCC-
CA, the anti-sense primer was TATTCCTGGTCGGCCAGGGGT, and
annealing was at 56°C for 90 s (Li et al, 1991). The α6 integrin subunit sense
primer was CTAACGGAGTCTCACAACTC, the anti-sense primer was
ACTCTGAAATCAGTCCTCAG, and annealing was at 60°C for 90 s
(Hogervorst et al, 1991). The β4 integrin subunit sense primer was CGGATGC-
TGCTTATTGAGAAC, the anti-sense primer was GAGGGTGGAGGATGT-
GCTTAG, and annnealing was at 59.4°C for 90 s. The Lam 5 β3 chain
sense primer was AACGTGGTGGGTCCCAAAT, the anti-sense primer was
TGCTCGGATCTGCTCAATCT, and annnealing was at 55°C for 45 s (Vailly
et al, 1995). The HGPRT sense primer was GGAGATGTGATGAAGGA-
GATGG, the anti-sense primer was GGATTATACTGCCTGACCAAGG, and
annealing was at 56°C for 90 s (Karp et al, 1993). An aliquot of the PCR
product was electrophoresed along with a 100-bp DNA ladder on a 1.8%
agarose gel containing ethidium bromide and photographed with positive/
negative film (Type 55, Polaroid, Santa Ana, CA). Along with each experiment
a negative control (RNA sample not reverse transcribed or buffer or double
deionized water) was also set up.
Figure 1. RT-PCR analysis of BPAG1 in BCC, NHS, and normal human
epidermal keratinocyte cultures reveals that expression in BCC is
markedly decreased when compared with the expression in NHS and
normal human epidermal keratinocytes that both show very similar
high levels of BPAG1 expression. BCC tumor samples (lanes 1–5), NHS
(lanes 6–8), normal human epidermal keratinocytes (lanes 9–10) as visualized
on an ethidium bromide stained agarose gel. In (a), the 426 bp PCR products
reveal substantially lower levels of BPAG1 in all BCC samples compared with
that in NHS and normal human epidermal keratinocytes. Note the very
similar levels of expression of BPAG1 in NHS and normal human epidermal
keratinocytes. No PCR product is seen in the sample from which cDNA was
omitted (lane 11). In (b), the 314 bp PCR products for HGPRT reveal very
similar loading for all lanes.
Verification and semiquantitation of PCR products To verify the speci-
ficity of the amplification reaction, electrophoresed PCR products were
transferred to a nylon membrane and probed with a fluorescein-labeled
oligonucleotide probe complementary to sequences within the region flanked by
the forward and reverse primers. The sequences of these specific oligonucleotides
(internal probes) were determined using the ‘‘OLIGO’’ software. The sequences
of the internal probes used were: BPAG1, CCTCAGCGGCCGAGAGAAT-
CATAATAGACA; BPAG2, GTTGGTGAGCCCGGGGCTAAAGGA; α6
integrin, GGCTATTCTCGCTGGGATCTTGATGCTTGCT; β4 integrin,
CTACACGGTGAAGGCGCGCAACGGGG; Lam 5 β3 chain, CTGCGCT-
TTGGTAGACTCCCGAATGCCACCGCCAGCCTGT; and HGPRT, GC-
TGACCTGCTGGATTACAT. The blots were hybridized with the fluorescein-
labeled probes overnight at 42°C. Further development and chemiluminescent
detection of the blots was performed using the manufacturer’s instructions (ECL
Kit, Amersham, Arlington Heights, IL).
PCR products were quantitated by densitometric scanning of both the
polaroid negatives and the autoradiography films, and the results were integrated
and normalized to the value of HGPRT. Statistical differences between groups
were assessed by the Students t test.
RESULTS
In our initial studies the BPAG1, BPAG2, α6 and β4 integrins, and β3
chain of Lam 5 mRNA could not be detected in BCC samples by
northern blot analysis using either total RNA or polyA RNA (data
not shown). We therefore used RT-PCR to study the level of
expression of these hemidesmosome-associated BM components in
BCC tumor samples.
RT-PCR analysis of hemidesmosome-associated BM compon-
ents in NHS and normal human epidermal keratinocytes cul-
tures reveals very similar results In preliminary RT-PCR
experiments, conditions (cycle number and template concentration)
were optimized for each gene to ensure amplification in the linear
range for each cDNA, and the same set of cDNA were further used
to compare expression of hemidesmosome-associated BM components
in BCC with that in NHS and normal human epidermal ker-
atinocyte cultures.
To determine whether normal human epidermal keratinocytes could
function as well as NHS as a control in the study of BM components,
we compared mRNA expression of BPAG1, BPAG2, α6 and β4
subunits of the α6β4 integrin, and Lam 5 (the β3 chain) in NHS and
normal human epidermal keratinocytes. Normal human epidermal
keratinocytes expressed all five BM components studied at essentially
the same levels as those seen in NHS. Figure 1a shows the data for
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Figure 2. PCR analysis of hemidesmosome-associated BM components in BCC and normal human epidermal keratinocyte samples reveals
diminished levels of BPAG1, BPAG2, the a6 and b4 subunits of the a6b4 integrin, and the b3 chain of Lam 5 in BCC as compared with normal
human epidermal keratinocytes. BCC tumor samples are found in lanes 1–10 and normal human epidermal keratinocytes in lanes 11–15. (a) The 426 bp PCR
products specific for the BPAG1; (b) the 390 bp PCR product specific for the BPAG2; (c) the 843 bp PCR product specific for the α6 integrin subunit; (d) the
414 bp PCR product specific for the β4 integrin subunit; (e) the 514 bp PCR product specific for the β3 chain of Lam 5; (f) the 314 bp PCR product specific for
HGPRT reveals very similar loading for all lanes. The ethidium bromide stained agarose gels in the upper panels reveal that all components are found at lower levels
in the BCC samples as compared with the normal human epidermal keratinocytes. The specificity of the PCR amplification reaction is revealed in the lower panels
that show that when the electrophoresed PCR products are probed with fluorescein-labeled oligonucleotide sequences specific for the BM component of interest,
a single product of the expected size is generated. In (a), (b), (d), and (e) no PCR products are seen in the samples from which cDNA was omitted (lane 16).
BPAG1 demonstrating that the levels of BPAG1 do not differ appreciably
in NHS and normal human epidermal keratinocytes. Evidence that
very similar amounts of DNA were loaded into each well is provided
by the HGPRT data in Fig 1b. Similar findings revealed that the levels
of expression in both NHS and normal human epidermal keratinocytes
did not differ appreciably for BPAG2, the α6 and β4 subunits of the
α6β4 integrin, and the β3 chain of Lam 5 (data not shown). Because
normal human epidermal keratinocytes are easier to obtain than NHS,
and the expressions of all BM components were very similar in both
normal human epidermal keratinocytes and NHS, we chose to perform
all further experiments using normal human epidermal keratinocytes
as the control. No PCR products were detected in any of the negative
controls, thus confirming the absence of any extraneous contamination
in the samples.
PCR analysis of hemidesmosome-associated BM components
in BCC and normal human epidermal keratinocyte samples
reveals diminished levels of BPAG1, BPAG2, the a6 and b4
subunits of the a6b4 integrin, and the b3 chain of Lam 5 in BCC
as compared with normal human epidermal keratinocytes The
expression of BPAG1 RNA was undetectable in three of 10 BCC
(Fig 2a, lanes 4, 5, and 8), substantially reduced in two of 10 BCC
(Fig 2a, lanes 1 and 3), and considerably reduced in five of 10 BCC
(Fig 2a, lanes 2, 6, 7, 9, and 10) when compared with the expression
in normal human epidermal keratinocytes. Quantitation of the PCR
products indicated that the mean PCR product intensity of BPAG1
mRNA was 4-fold less in BCC (p , 0.01) than that observed in
normal human epidermal keratinocytes (Fig 3). The mRNA levels of
BPAG2 were undetectable in four of 10 BCC (Fig 2b, lanes 1, 2, 7,
and 10), substantially reduced in five of 10 BCC (Fig 2b, lanes 3, 4,
5, 8, and 9), and minimally reduced in one of 10 BCC (Fig 2b, lane
6) when compared with the expression in normal human epidermal
keratinocytes. The mean PCR product intensity of BPAG2 mRNA
was 2-fold less in BCC as compared with normal human epidermal
keratinocytes (p , 0.05) (Fig 3). mRNA expression of the α6 subunit
Figure 3. Semiquantitative comparison of BM component mRNA in
BCC and normal human epidermal keratinocytes reveals significantly
lower levels of all BM components evaluated in BCC as compared with
normal human epidermal keratinocytes. Data represented as mean 1 SEM.
Total RNA was reverse transcribed and PCR amplified using gene specific
primers, as discussed in Materials and Methods. PCR products were electro-
phoresed on agarose gel containing ethidium bromide and quantitation of the
signals was carried out by densitometric scanning of the Polaroid negatives.
The densitometric value of each amplified sample was normalized to the
corresponding value of HGPRT.
of the α6β4 integrin was undetectable in one of 10 BCC (Fig 2c, lane
3) and substantially reduced in nine of 10 BCC (Fig 2c, lanes 1, 2,
and 4–10) when compared with the expression in normal human
epidermal keratinocytes. Quantitative analysis showed that the mean
PCR product intensity of the α6 integrin subunit mRNA was nearly
2.5 times less in BCC than in normal human epidermal keratinocytes
(p , 0.001) (Fig 3). The β4 integrin subunit mRNA levels were
substantially reduced in two of 10 BCC (Fig 2d, lanes 3 and 10) and
considerably reduced in eight of 10 BCC (Fig 2d, lanes 1, 2, and 4–
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9) when compared with the expression in normal human epidermal
keratinocytes. The mean PCR product intensity of the β4 integrin
subunit mRNA was 1.5 times less in BCC than in normal human
epidermal keratinocytes (p , 0.001) (Fig 3). Lam 5 (the β3 chain)
mRNA expression was substantially reduced in nine of 10 BCC
(Fig 2e, lanes 1–5 and 7–10) and minimally reduced in one of 10 BCC
(Fig 2e, lane 6) when compared with the expression in normal human
epidermal keratinocytes. The mean PCR product intensity of Lam 5
mRNA was more than 3-fold reduced in BCC when compared with
normal human epidermal keratinocytes (p , 0.001) (Fig 3). Evidence
that very similar amounts of DNA were loaded into each well is
provided by the HGPRT data in Fig 2f. Similar HGPRT data was
obtained for Fig 2(a, b, d, e). No PCR products were detected in any
of the negative controls (Fig 2a, b, d, e, lane 16), thus confirming the
absence of any extraneous contamination in the samples.
Southern blot studies confirm the RT-PCR analysis and reveal
that each PCR reaction was specific for the BM component
amplified Further verification and quantitation of these PCR prod-
ucts was accomplished using fluorescein-labeled oligonucleotides
specific for the amplified sequences of the BM components. These
Southern blots probed with specific fluorescein-labeled oligonucleotides
confirmed that each PCR was specific for the BM component amplified
(Fig 2a–e, lower panels).
DISCUSSION
In this study we have demonstrated that BCC display significantly
decreased levels of mRNA encoding for several hemidesmosome-
associated components including BPAG1, BPAG2, the α6 and β4
subunits of the α6β4 integrin, and the β3 chain of Lam 5. Our studies
evaluate the molecular mechanisms underlying the previously observed
alterations in BM components in BCC.
Because BPAG1, BPAG2, the α6β4 integrin, and Lam 5 all play a
role in the attachment of basal keratinocytes to the BM, and we have
found decreased levels of the mRNA encoding for all of these
components, we suggest that these alterations may play a role in the
ability of BCC to invade tissue. Concurrent alterations in expression
of both the α6β4 integrin receptor and its ligand, Lam 5, in BCC both
at the protein level as previously demonstrated (Korman and Hrabovsky,
1993) and at the mRNA level as shown in the present study, supports
the previously suggested coregulation of this receptor-ligand pair
(Savoia et al, 1993). The α6β4 integrin displays increased levels and
altered expression in both mouse epidermal squamous cell carcinomas
(SCC) and mouse SCC cell lines (Tannenbaum et al, 1992; Gomez
et al, 1992), although decreased levels in human oral SCC but not
cutaneous SCC (Downer et al, 1993; Savoia et al, 1993). These
observations suggest that regulation of the α6β4 integrin may be
differentially controlled at least in part as a function of species variation
in SCC, but further work will be required to better understand the
basis for the differences between BCC and SCC.
The abnormalities in numerous BM components that we and others
have previously demonstrated could be due to enhanced catabolism
by enzymatic degradation, or impaired production, assembly, or secre-
tion by the BCC tumor cells. The best known model for BM invasion
of tumors derives from extensive work in epithelial tumors (Liotta
et al, 1984). The tumor cells first attach to the BM via cell surface
receptors and the attached tumor cells secrete or induce other neighbor-
ing cells to secrete proteolytic enzymes. These enzymes degrade the
BM and the tumor cell is then able to migrate across the BM.
Support for this mechansim in BCC derives from the observation that
papulonodular BCC have increased levels of type I collagenase (Barsky
et al, 1987) that can degrade type VII collagen (Seltzer et al, 1989).
The BPAG2 has collagenous domains that are susceptible to collagenase
digestion (Giudice et al, 1992), suggesting that this component could be
degraded by the increased levels of collagenase present in papulonodular
BCC. Recent studies have also demonstrated that eosinophils around
BCC may elaborate type IV collagenase that could also aid in the
degradation of matrix components (Stahle-Backdahl et al, 1992).
The findings presented here support an alternate hypothesis to
explain the mechanism responsible for BCC tumor invasion. It is
known that normal keratinocytes can synthesize most epidermal BM
components (Stanley et al, 1982b, 1985; Oguchi et al, 1985; Carter
et al, 1990, 1991) and that the epidermal BM is a dynamic structure
continuously being catabolized and redeposited (Kefalides et al, 1979).
Therefore, the presence of a clone of malignant keratinocytes incapable
of adequate synthesis of BM components may render that BM more
susceptible to tumor invasion. A recent study provides genetic evidence
that sporadic BCC develop by clonal evolution and supports the notion
that a series of mutations in a single cell is responsible for the
abnormalities observed in these tumors (Walsh et al, 1996). In fact, the
gene thought to be responsible for the development of BCC in patients
with the basal cell nevus syndrome and in patients with sporadic BCC
has been identified as the human homolog of the drosophila patched
gene (Gailani et al, 1996; Johnson et al, 1996). The patched gene
encodes a protein that inhibits another signaling molecule that controls
cell differentiation and growth in numerous tissues. These observations
lend further credence to our hypothesis that BCC may have a defective
BM due to the presence of a clone of malignant keratinocytes that are
unable to successfully synthesize BM components and that this altered
BM may facilitate tumor invasion.
We have found that the BM underlying BCC displays global
abnormalities in the synthesis of numerous epidermal BM-specific
mRNA. Further support for this concept is derived from the observation
that in a cell culture model for BCC, malignant basal keratinocytes fail
to express bullous pemphigoid antigens whereas nonmalignant basal
keratinocytes from the same patient show bullous pemphigoid antigen
expression (Brysk et al, 1992). In addition, GB3 antigen (now known
as Lam 5), which is expressed in normal keratinocytes, is absent from
virally transformed keratinocytes (Verrando et al, 1987). Furthermore,
type VII collagen synthesis in virally transformed keratinocytes is also
significantly diminished when compared with normal keratinocytes
(Ryynanen et al, 1992). Similar changes revealing the absence of several
hemidesmosomal proteins have been observed in the basal cells of
prostate carcinoma (Nagle et al, 1995) and for the α6 and β4 integrin
subunits in breast epithelium (Jones et al, 1992).
The loss of several hemidesmosomal components from virally
transformed keratinocytes, BCC, breast epithelium, and prostate carcin-
oma suggests that these BM alterations are specific to transformed
epithelial cells and may play an important role in the ability of epithelial
tumors to invade underlying tissues. These observations provide support
for our hypothesis that BCC tumor cells may possess an impaired ability
to synthesize the normal complement of epidermal BM components and
that the absence of a normal BM facilitates tumor invasion. Our
hypothesis is offered as an additional explanation to account for BM
invasion of BCC and is not meant to suggest that the proteolysis model
is invalid. We believe that it is likely that BCC tumor invasion occurs
due to a combination of the proteolytic degradation of the epidermal
BM along with the diminished synthesis of several BM components
by the tumor cells. The studies reported here initiate an understanding of
the molecular mechanisms that may play a role in BCC tumor invasion.
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